Medscape: 7 hours outdoors halves myopia risk

Researchers studying childhood myopia are trying to solve two problems at once: how to measure children’s real-world outdoor exposure, and how to identify which children are at higher risk of becoming nearsighted. A Spanish research group says conjunctival ultraviolet autofluorescence, or CUVAF, may help with both. The measure captures ultraviolet-related fluorescence on the eye’s conjunctiva and has been studied as an objective marker of time spent outdoors. Medscape reported this month that the work was discussed at ARVO 2026, the annual meeting of the Association for Research in Vision and Ophthalmology, held May 3-7 in Denver. ### What exactly did the researchers study? A June 2024 ARVO abstract described a case-control analysis in a school cohort of 2,616 children in Madrid, ages 7 and 12, recruited from 39 schools. Sergio Recalde and colleagues compared CUVAF area in children with and without myopia and also collected questionnaire data on lifestyle and myopia history. The children underwent objective refraction, axial length measurement, fundus photography and CUVAF imaging with a Heidelberg Spectralis device, according to the abstract. (ncbi.nlm.nih.gov) A December 9, 2024 paper in *Frontiers in Medicine* by Miriam de la Puente, Valentina Bilbao-Malavé, Jorge González-Zamora and co-authors reported the same line of work from Clínica Universidad de Navarra and collaborators. The paper identified CUVAF as a biomarker of outdoor time in myopic children and listed Sergio Recalde as corresponding author. (iovs.arvojournals.org) ### What did they find in the Madrid children? The ARVO abstract reported that 305 of the 2,616 children were myopic and 2,184 were non-myopic controls. The researchers said the control group had significantly larger CUVAF areas than the myopic group, and that zero-area CUVAF measurements were more common in myopic children, especially in grade 2 and high-myopia groups. The abstract also reported a significant correlation between CUVAF area and spherical equivalent refraction. (frontiersin.org) Medscape reported that at least seven hours a week outdoors may cut children’s myopia risk by about half, citing the same research stream presented around ARVO 2026. That figure fits the broader literature linking more outdoor exposure with less myopia, though the open ARVO abstract available online emphasizes the association between larger CUVAF areas and lower myopia rather than reproducing the full Medscape wording. (iovs.arvojournals.org) ### Why are researchers interested in CUVAF instead of just asking parents? A 2024 systematic review and meta-analysis in *Scientific Reports* said outdoor exposure is considered the main modifiable risk factor for preventing myopia development, but measuring it has been difficult because most studies rely on self-report. The review said CUVAF has emerged as an objective, quantifiable biomarker for sun exposure and summarized nine studies involving 3,615 individuals across Australia, Europe and India. (medscape.com) The same review found that myopic participants generally had smaller CUVAF areas than non-myopic participants, with a pooled mean difference of negative 3.30 square millimeters. It also found that myopic participants reported less outdoor exposure than non-myopic participants, with a pooled mean difference of negative 3.38 hours per week. ### Does this mean sunlight itself is being prescribed? (ncbi.nlm.nih.gov) The *Scientific Reports* review said the protective effect of outdoor exposure is thought to be related to light-induced dopamine synthesis and release in the retina. The CUVAF work does not amount to a treatment recommendation on its own; it is being studied as a screening and research tool that could give investigators a faster, less subjective way to sort children by likely outdoor exposure and myopia risk. (ncbi.nlm.nih.gov) ARVO’s official schedule shows the 2026 annual meeting ran May 3-7 in Denver, where new ophthalmology findings were presented across paper and poster sessions. The published paper and the meeting abstract leave the next step with named investigators including Recalde and de la Puente: testing whether CUVAF can be used consistently in larger population studies of children and whether it improves myopia-risk screening beyond questionnaires alone. (ncbi.nlm.nih.gov) (arvo.org)